The Unrealized Potential of 34mCl for Radiopharmaceutical Research with PET

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|4|2|102-108

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.4, Iss.2, 2011-04, pp. : 102-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiosynthesis of 8-Fluoro-3-(4-[18F]Fluorophenyl)-3,4-Dihydro-1-Isoquinolinamine ([18F]FFDI), a Potential PET Radiotracer for the Inducible Nitric Oxide Synthase

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 2, 2008-05 ,pp. : 49-53

Bentham Science Publishers

Access to resources Recommend Favorite

PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 1, 2018-04 ,pp. : 4-13

Bentham Science Publishers

Access to resources Recommend Favorite

Technetium-99m Cysteine; A Novel Radiopharmaceutical for Detection of Experimental Myocardial Infarction in Rats

By  

Current Radiopharmaceuticals, Vol. 3, Iss. 4, 2010-10 ,pp. : 290-296

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting PI3K/Akt/mTOR Cascade: The Medicinal Potential, Updated Research Highlights and Challenges Ahead

By  

Current Medicinal Chemistry, Vol. 20, Iss. 24, 2013-08 ,pp. : 2991-3010

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [ Advances in Heme Oxygenase Research as a Potential Therapeutic Strategy Executive Editor: M.J. Alcaraz]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 411-411

Bentham Science Publishers

Access to resources Recommend Favorite